ES2176271T3 - Metodo para juzgar la erradicacion de h.pylori basado en las tasas de cambios en la relacion pepsinogeno i/ii. - Google Patents

Metodo para juzgar la erradicacion de h.pylori basado en las tasas de cambios en la relacion pepsinogeno i/ii.

Info

Publication number
ES2176271T3
ES2176271T3 ES95115371T ES95115371T ES2176271T3 ES 2176271 T3 ES2176271 T3 ES 2176271T3 ES 95115371 T ES95115371 T ES 95115371T ES 95115371 T ES95115371 T ES 95115371T ES 2176271 T3 ES2176271 T3 ES 2176271T3
Authority
ES
Spain
Prior art keywords
pylori
eradication
judging
pepsinogen
relationship
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95115371T
Other languages
English (en)
Inventor
Takahisa Dr Furuta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2176271T3 publication Critical patent/ES2176271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTA UN METODO DE JUICIO DE LA ERRADICACION DE H.PYLORI PARA JUZGAR SI LA MUESTRA ES POSITIVA O NEGATIVA A TRAVES DE UNA OPERACION FACIL Y RAPIDA. SE MIDE UN VALOR PG I Y UN VALOR PG II EN LOS FLUIDOS CORPORALES (POR EJEMPLO, EN LA SANGRE ) DE UN PACIENTE CON H.PYLORI POSITIVA ANTES DEL TRATAMIENTO DE ERRADICACION DE LA H.PYLORI Y DESPUES DE QUE TRANSCURRA UN PERIODO EN EL QUE SE OBTIENE UN RESULTADO SUSTANCIALMENTE SIGNIFICATIVO DEL TRATAMIENTO DE ERRADICACION, SE ENCUENTRE UNA RAZON PG I/PG II EN LOS FLUIDOS CORPORALES (POR EJEMPLO, LA SANGRE ), SE ENCUENTRE UNA VELOCIDAD DE CAMBIO EN LA RAZON PG I/PG II EN LOS FLUIDOS CORPORALES (POR EJEMPLO, LA SANGRE) ANTES DEL TRATAMIENTO DE ERRADICACION DE H.PYLORI Y DESPUES DE QUE TRANSCURRA EL PERIODO EN EL QUE SE OBTIENEN LOS RESULTADOS SUSTANCIALMENTE SIGNIFICATIVOS DEL TRATAMIENTO DE ERRADICACION. EL CAMBIO EN LA RAZON PG I/PG II ES UTILIZADO COMO UN MARCADOR PARA INDICAR QUE LA H.PYLORI HA SIDO ERRADICADA.
ES95115371T 1995-08-28 1995-09-29 Metodo para juzgar la erradicacion de h.pylori basado en las tasas de cambios en la relacion pepsinogeno i/ii. Expired - Lifetime ES2176271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7240418A JP2949474B2 (ja) 1995-08-28 1995-08-28 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法

Publications (1)

Publication Number Publication Date
ES2176271T3 true ES2176271T3 (es) 2002-12-01

Family

ID=17059187

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95115371T Expired - Lifetime ES2176271T3 (es) 1995-08-28 1995-09-29 Metodo para juzgar la erradicacion de h.pylori basado en las tasas de cambios en la relacion pepsinogeno i/ii.

Country Status (7)

Country Link
US (1) US6156525A (es)
EP (1) EP0760482B1 (es)
JP (1) JP2949474B2 (es)
AT (1) ATE221201T1 (es)
DE (1) DE69527526T2 (es)
DK (1) DK0760482T3 (es)
ES (1) ES2176271T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
US20050048665A1 (en) 2003-08-25 2005-03-03 Nutriag Ltd. pH colour indicator for use with agricultural compounds
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
CN114835815B (zh) * 2022-06-07 2023-06-30 宁波赛珀生物技术有限公司 一种抗胃蛋白酶原i的单克隆抗体及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830010A (en) * 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
DE69527526T2 (de) 2003-05-08
JP2949474B2 (ja) 1999-09-13
DK0760482T3 (da) 2002-11-18
JPH0961428A (ja) 1997-03-07
EP0760482B1 (en) 2002-07-24
DE69527526D1 (de) 2002-08-29
US6156525A (en) 2000-12-05
ATE221201T1 (de) 2002-08-15
EP0760482A2 (en) 1997-03-05
EP0760482A3 (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE273024T1 (de) Vorrichtung zur erhöhung der flüssigkeitsdurchflussgeschwindigkeit in einem biologischen gewebe mit mikroporen
DE69637553D1 (de) Vorrichtung zum Detektieren eines Analyten und zur Verabreichung einer therapeutischen Substanz
NO20014869L (no) Vevsinhibitorer av matriks metallproteinaser type-1 (TIMP-1) som en kreftmarkör
NO20005800D0 (no) Fremgangsmåte og apparat for inaktivering av forurensninger i biologisk fluid
NO20013004L (no) Anvendelse av biokjemiske substanser i en sammensetning for forhindringen og behandlingen av helsetilstander forårsaket avkonstriksjon av glattmuskelceller i organer i det menneskeligelegemet
ATE195411T1 (de) Medizinisches gerät zum injizieren und/oder absaugen von flüssigkeiten in ein bzw. aus einem hohlorgan, insbesondere einem gallengang
EP0439629A4 (en) Device for irradiating laser beams
AU2036195A (en) Indicating device and method for marking out and forming one or more attachment points for a fixture or fixtures in an area of the human body, preferably the jaw
CA2254018A1 (fr) Procede de determination d'un parametre significatif du progres d'un traitement extracorporel de sang
BR9910570A (pt) Aparelho para o tratamento de distúrbios de tecido e/ou das juntas
DE69637181D1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
DE69533674D1 (de) Verfahren und anschlusselement zur sterilen übertragung einer lösung mit hilfe eines verbinders
DE68921468D1 (de) Vorrichtung und reagens für die kataraktchirurgie.
ES2176271T3 (es) Metodo para juzgar la erradicacion de h.pylori basado en las tasas de cambios en la relacion pepsinogeno i/ii.
ATE286674T1 (de) Anordnung zum behandlen von krankheiten
ATE314826T1 (de) Verfahren und vorrichtung zur begrenzung des drehmomentes zahnärztlicher und chirurgischer handstücke
ATE191976T1 (de) Verfahren zum nachweis von knochen- und anderen bindegewebeerkrankungen in menschen und tieren
EE200300453A (et) Seade ja meetod vedelike töötlemiseks ultraheliga
DE3864984D1 (de) Verfahren und einrichtung zur sterilisation des zerstaeubers und/oder der luftzufuhr von medizinischen instrumenten, insbesondere von zahnaerztlichen instrumenten.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ATE329638T1 (de) Vorrichtung, um in einem zielgebiet eines menschlichen oder tierischen körpers einen künstlichen isolierten kreislauf zu etablieren
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK312889A (da) Vaeske til konditionering af tand- eller knoglesubstanser, deres fremstilling og anvendelse